Navigation Links
Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
Date:1/13/2009

- Merck Serono and Apitope to Collaborate on Development and Commercialization of ATX-MS-1467, Apitope's Peptide Therapeutic for the Treatment of Multiple Sclerosis (MS)

GENEVA, Jan. 13 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the signature of a research, development and commercialization agreement with Apitope Technology (Bristol) Ltd., a wholly owned subsidiary of Apitope International NV. Under this agreement, Apitope has granted exclusive worldwide rights to Merck Serono to develop and commercialize Apitope's product ATX-MS-1467. This peptide therapeutic has completed an initial clinical study in patients with multiple sclerosis (MS). It is designed to induce immunological tolerance of the body's T-cells to key autoantigens involved in the pathogenesis of MS.

ATX-MS-1467 is a novel peptide-based therapeutic derived from Apitope's proprietary technology platform. Under the terms of the agreement, Apitope will receive an upfront payment and will initially be responsible for the further development of ATX-MS-1467, for which Merck Serono will fund the costs. Merck Serono will be responsible for all development activities from the beginning of Phase II clinical trials. Merck Serono will also provide committed funding to Apitope for research on other novel therapeutic peptides for the treatment of MS.

Under the terms of the agreement, Apitope is eligible to receive up to EUR 154 million in upfront, development and commercialization milestone payments, in addition to royalties on the net sales of products resulting from the collaboration.

"This partnership with Apitope strengthens our position as a leader in the field of innovative research and development in multiple sclerosis," said Bernhard Kirschbaum, Executive Vice President Research and Development at Merck Serono. "ATX-MS-1467 represents a novel, targeted approach and may have the potenti
'/>"/>

SOURCE Merck Serono
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
2. ARVO Foundation and Merck to provide prestigious global ophthalmic research award
3. Prasco to Distribute Generic Forms of Dorzolamide Hydrochloride-Timolol Maleate and Dorzolamide Hydrochloride Ophthalmic Solutions (Comparable to Mercks COSOPT(R) and TRUSOPT(R) Ophthalmic Solutions)
4. Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance
5. Mercks odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study
6. Covance Recognized for Outstanding Performance by Merck & Co., Inc.
7. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
8. Schiffrin Barroway Topaz & Kessler, LLP Announces Court Ruling Relating to Merck & Co. Inc.s Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, and the Merck Puerto Rico Employee Savings & Security Plan
9. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
10. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
11. UNICEF & Merck Partner to Protect 100,000 Children and Young People Against Mumps Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... that turns 160 years of neuroanatomy on its head. ... be essential for the fast transmission of impulses along ... as thought, according to a new work lead by ... (HSCI) and the University,s Department of Stem Cell and ... Harvard,s Department of Molecular and Cellular Biology. , "Myelin ...
(Date:4/18/2014)... University psychologists have made a brain-related discovery that ... disorders. , This discovery opens up the possibility ... suppress a specific brain activity that the researchers ... The Journal of Neuroscience has just ... McDonald, an associate professor of psychology and his ...
(Date:4/17/2014)... The presence of chronic inflammation in benign ... prostate cancer, and this association was found even ... according to a study published in Cancer ... the American Association for Cancer Research. , An ... participants of the placebo arm of the Prostate ...
(Date:4/17/2014)... popular vaccine brands for children may not be the ... cost factors when choosing vaccines, driving the market toward ... a new study by University of Illinois researchers. , ... by numerous factors," says Sheldon H. Jacobson, a co-author ... and of mathematics at the U. of I. "In ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2
... South Florida stated that a restricted low-carbohydrate diet doesn’t increase ... prescribed for weight loss and it was published in the ... ,A more broadly used weight reducing technique nowadays is a ... side effects. One among that is the low carbohydrate diet, ...
... is a good way of relieving stress and providing the ... shown that exercise can lift a person's spirits// , and ... treating clinical depression. Exercise helps in the reduction of anger, ... Retro walking or running has become popular among health freaks. ...
... Indian Medical Association today said that private doctors have announced ... for OBCs // , and have decided to close their ... Dental Association, Rajkot, have also extended its support to anti-quota ... release here., ,At least 70 medical students and junior ...
... anti-reservation medicos in India Friday held their first direct talks ... strike. // ,Singh had an hour-long meeting with ... a massive expansion of the higher education system which would ... all classes and categories of students., ,The Prime Minister ...
... Minister- Mr.Manmohan Singh today met representatives of the medical ... days//. The students came from institutions inside Delhi and across ... of demands which they wanted the Prime Minister and the ... future of their fellow students. ,The Prime Minister ...
... silent shift in drug usage in northeastern states, says a ... "Drug Use in the Northeastern States of India" says that ... of drugs in the early 80s. These years there has ... the dominant users of these drugs, while female users constitute ...
Cached Medicine News:Health News:Low Carbohydrate Diet Packs No Bone Loss 2
(Date:1/15/2014)... 15, 2014  Novation, the leading health care supply chain ... value-added reseller (VAR) national contracts that expand its portfolio ... at lower costs. These include manufacturer product and service ... assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will receive ... Journal of Drugs in Dermatology (JDD) at the ... event is January 17-20, 2014, at the Omni Orlando Resort at ... The ODAC is a distinguished event that delivers ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very ... King as its new Chief Executive Officer.  Mark was ... which he has overseen the company,s four facilities in ... Costa Rica.  Mr. King joined Tegra Medical in 2012 with ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Sept. 17 Henry Schein, Inc., (Nasdaq: HSIC ... to office-based practitioners, announced today that Steven Paladino, Henry Schein,s ... the UBS Global Life Sciences Conference at the Grand Hyatt ... begin at 9 a.m. EDT and can be heard via ...
... BIOD ) announced today the appointment of Arthur ... chairman of ArcherGroup, a private investment and consulting services firm, ... Kroll Bond Rating Agency.  He is a retired chairman of ... spent 30 years at Merrill Lynch & Company where he ...
Cached Medicine Technology:Henry Schein to Present at the UBS Global Life Sciences Conference 2Biodel Appoints Arthur Urciuoli to its Board of Directors 2Biodel Appoints Arthur Urciuoli to its Board of Directors 3
Straight shafts with 0.12 mm teeth and 5 mm tying platform. Serrated handle with polished finish. Manufactured in titanium....
Angled 45 degree shafts with 0.5 teeth and 6 mm tying platform. Polished finish....
Angled 45 degree shafts 8 mm long with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Colibri style tips. Double toothed tips with 0.10 mm teeth spaced 1 mm apart and 7 mm tying platform. Wide serrated handle with polished finish....
Medicine Products: